FBLG Earnings — FibroBiologics, Inc. Common Stock Post-ER Performance | BigEarnings
FBLG — FibroBiologics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.16
Market Cap$6.0M
P/E—
52W Range$0.95 – $19.80
Next Earnings2026-07-30
About FibroBiologics, Inc. Common Stock
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
